Federal Register / Vol. 75, No. 184 / Thursday, September 23, 2010 / Notices 57965 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Member 

Conflict SEP. 

Date: October 4, 2010. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20892. 

Contact Person: Ramesh Vemuri, PhD, 

Chief, Scientific Review Branch, National 

Institute on Aging, National Institutes of 

Health, 7201 Wisconsin Avenue, Suite 2C– 

212, Bethesda, MD 20892, 301–402–7700, 

rv23r@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Autophagy, 

Inflammaging and Immunosenescence. 

Date: October 14, 2010. 

Time: 1 p.m. to 5 p.m. 

Agen To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Elaine Lewis, PhD, 

Scientific Review Branch, National Institute 

on Aging, Gateway Building, Suite 2C212, 

MSC–9205, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, 301–402–7700, 

elainelewis@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Perimenopause and Aging. 

Date: November 4, 2010. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Alicja L. Markowska, PhD, 

DSC., Scientific Review Branch, National 

Institute on Aging, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20892, 301–496– 

9666, markowsa@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: September 16, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23848 Filed 9–22–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Musculoskeletal 

Rehabilitation Sciences Study Section, 

October 8, 2010, 8 a.m. to October 8, 

2010, 6 p.m., Hilton Alexandria Old 

Town, 1767 King Street, Alexandria, 

VA, 22314 which was published in the 

Federal Register on September 1, 2010, 

75 FR 53702–53703. 

The meeting will be held October 7, 

2010 to October 8, 2010. The meeting 

time and location remain the same. The 

meeting is closed to the public. 

Dated: September 16, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23847 Filed 9–22–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Macromolecular Structure and Function C. 

Date: October 7, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Avenue, NW., Washington, DC 20037. 

Contact Person: Nitsa Rosenzweig, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1102, 

MSC 7760, Bethesda, MD 20892, (301) 435– 

1747, rosenzweign@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Drug Discovery. 

Date: October 12, 2010. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Syed M. Quadri, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6210, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1211, quadris@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA Panel: 

Drug Discovery for the Nervous System. 

Date: October 14–15, 2010. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: InterContinental Chicago Hotel, 505 

North Michigan Avenue, Chicago, IL 60611. 

Contact Person: Mary Custer, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4148, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1164, custerm@csr.nih.gova. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; Cellular 

Aspects of Diabetes and Obesity Study 

Section. 

Date: October 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Nikko San Francisco, 222 

Mason Street, San Francisco, CA 94102. 

Contact Person: Robert Garofalo, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 6156, 

MSC 7892, Bethesda, MD 20892, 301–435– 

1043, garofalors@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Neurotransporters, Receptors, 

and Calcium Signaling Study Section. 

Date: October 14–15, 2010. 

Time: 8:30 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 


srobinson on DSKHWCL6B1PROD with NOTICES
57966 Federal Register / Vol. 75, No. 184 / Thursday, September 23, 2010 / Notices 

Place: Melrose Hotel, 2430 Pennsylvania 

Avenue, NW., Washington, DC 20037. 

Contact Person: Peter B. Guthrie, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4182, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1239, guthriep@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA Panel: 

Drug Discovery for the Nervous System. 

Date: October 15, 2010. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: InterContinental Chicago Hotel, 505 

North Michigan Avenue, Chicago, IL 60611. 

Contact Person: Mary Custer, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4148, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1164, custerm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts: Bioengineering Sciences and 

Technologies. 

Date: October 25, 2010. 

Time: 1 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Raymond Jacobson, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5858, 

MSC 7849, Bethesda, MD 20892, 301–996– 

7702, jacobsonrh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Neuronal 

Injury and Eye Disease. 

Date: October 26, 2010. 

Time: 10 a.m. to 9 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Kevin Walton, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5200, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1785, kevin.walton@nih.hhs.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Visual Systems. 

Date: October 28, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Luxury Hotel & Suites, 

2033 M Street, NW., Washington, DC 20036. 

Contact Person: George Ann McKie, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5192, 

MSC 7846, Bethesda, MD 20892, 301–996– 

0993, mckiegeo@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–10– 

134: Understanding and Promoting Health 

Literacy. 

Date: October 28, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Michael Micklin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3136, 

MSC 7759, Bethesda, MD 20892, (301) 435– 

1258, micklinm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Non-HIV Anti-Infective 

Therapeutics. 

Date: October 28–29, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Harborplace Hotel, 202 

East Pratt Street, Baltimore, MD 21202. 

Contact Person: Rossana Berti, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3191, 

MSC 7846, Bethesda, MD 20892, 301–402– 

6411, bertiros@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; TW 09–002: 

International Collaborative Trauma and 

Injury Research. Training Program. 

Date: October 28–30, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Inese Z. Beitins, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3218, 

MSC 7808, Bethesda, MD 20892, 301–435– 

1034, beitinsi@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Fellowship: 

F07 Immunology Fellowship AREA. 

Date: October 28–29, 2010. 

Time: 8:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Calbert A Laing, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4210, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1221, laingc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Diabetes, Obesity and Reproductive 

Science. 

Date: October 28–29, 2010. 

Time: 11 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Krish Krishnan, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6164, 

MSC 7892, Bethesda, MD 20892, (301) 435– 

1041, krishnak@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Vision 

Sciences and Technology. 

Date: October 29, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Luxury Hotel & Suites, 

2033 M Street, NW., Washington, DC 20036. 

Contact Person: George Ann McKie, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5192, 

MSC 7846, Bethesda, MD 20892, 301–996– 

0993, mckiegeo@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR10–141: 

Transforming Biomedicine at Interface of the 

Life and Physical Sciences. 

Date: October 29, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Malgorzata Klosek, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4188, 

MSC 7849, Bethesda, MD 20892, (301) 435– 

2211, klosekm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Cellular and Molecular 

Immunology. 

Date: October 29, 2010. 

Time: 10 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Stephen M. Nigida, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4212, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1222, nigidas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA10–014: 

Strengthening Behavioral and Social Science 

in Medical School Education (R25). 

Date: October 29, 2010. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Dana Jeffrey Plude, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3176, 

MSC 7848, Bethesda, MD 20892, 301–435– 

2309, pluded@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 184 / Thursday, September 23, 2010 / Notices 57967 

Dated: September 16, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23846 Filed 9–22–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group; Aging Systems and Geriatrics Study 

Section. 

Date: October 4, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriot, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: James P Harwood, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5168, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1256, harwoodj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA Panel: 

Scientific Models to Improve Health. 

Date: October 20, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Marriott Wardman Park 

Hotel, 2660 Woodley Road, NW., 

Washington, DC 20008. 

Contact Person: Hilary D Sigmon, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, (301) 594– 

6377, sigmonh@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 16, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23844 Filed 9–22–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0001] 

Science Advisory Board to the 

National Center for Toxicological 

Research Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). At least one portion of the 

meeting will be closed to the public. 

Name of Committee: Science 

Advisory Board (SAB) to the National 

Center for Toxicological Research 

(NCTR). 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on October 19, 2010, from 8:15 

a.m. to 5:30 p.m. and on October 20, 

2010, from 8:30 a.m. to 1 p.m. 

Location: National Center for 

Toxicological Research, 3900 NCTR Dr., 

Jefferson, AR 72079, Conference Room 

B–12. 

Contact Person: Margaret Miller, 

NCTR, Food and Drug Administration, 

10903 New Hampshire Ave., Bldg. 32, 

rm. 2208, Silver Spring, MD, 20993– 

0002, 301–796–8890, or FDA Advisory 

Committee Information Line, 1–800– 

741–8138 (301–443–0572 in the 

Washington, DC area), code 301–451– 

2559. Please call the Information Line 

for up-to-date information on this 

meeting. A notice in the Federal 

Register about last minute modifications 

that impact a previously announced 

advisory committee meeting cannot 

always be published quickly enough to 

provide timely notice. Therefore, you 

should always check the agency’s Web 

site and call the appropriate advisory 

committee hot line/phone line to learn 

about possible modifications before 

coming to the meeting. 

Agenda: On October 19, 2010, NCTR 

Director will provide a Center-wide 

update on scientific endeavors and 

discuss prioritization, alignment, and 

the strategic focus of NCTR. The SAB 

will be presented with updates from 

each of the NCTR divisions on their 

individual accomplishments and future 

research plans based on the major items 

identified in the last subcommittee 

review. The report of the subcommittee 

review of the Division of 

Neurotoxicology will be presented for 

discussion and adoption by the full 

Board. On October 20, 2010, the SAB 

will be presented with and discuss the 

NCTR Strategic Focus and future 

direction, and the need for research and 

potential collaborations. A discussion 

will be conducted on the organization of 

the SAB, site visits and SAB 

assignments. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ 

AdvisoryCommittees/Calendar/ 

default.htm. Scroll down to the 

appropriate advisory committee link. 

Procedure: On October 19, 2010, from 

8:15 a.m. to 5:30 p.m., the meeting is 

open to the public. Interested persons 

may present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before October 18, 2010. 

Oral presentations from the public will 

be scheduled between approximately 12 

p.m. to 1 p.m. Those desiring to make 

formal oral presentations should notify 

the contact person and submit a brief 

statement of the general nature of the 

evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before October 8, 2010. Time allotted 

for each presentation may be limited. If 

the number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by October 11, 2010. 

Closed Committee Deliberations: On 

October 20, 2010, from 12 p.m. to 1 

p.m., the meeting will be closed to 

permit discussion where disclosure 

would constitute a clearly unwarranted 


srobinson on DSKHWCL6B1PROD with NOTICES